Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis
For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Read More
Compliance and Cost of Biologic Therapies for Rheumatoid Arthritis
Medication compliance is associated with lower overall and disease-related healthcare costs in patients with moderate to severe rheumatoid arthritis receiving biologic therapies.
Read More